Geode Capital Management, LLC Viking Therapeutics, Inc. Transaction History
Geode Capital Management, LLC
- $1.12 Trillion
- Q2 2024
A detailed history of Geode Capital Management, LLC transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,859,082 shares of VKTX stock, worth $115 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,859,082
Previous 2,326,779
20.1%
Holding current value
$115 Million
Previous $191 Million
48.35%
% of portfolio
0.01%
Previous 0.02%
Shares
28 transactions
Others Institutions Holding VKTX
# of Institutions
442Shares Held
63.3MCall Options Held
6.23MPut Options Held
2.97M-
Vanguard Group Inc Valley Forge, PA10.1MShares$622 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$371 Million0.01% of portfolio
-
State Street Corp Boston, MA5.12MShares$316 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.25MShares$139 Million0.01% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA1.4MShares$86.6 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $4.73B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...